Sort   by:  
 Page size 
UnknownCancer proteogenomics: current impact and future prospects.
Not available
S-EPMC12404316 | biostudies-literature
UnknownProteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers.
Not available
S-EPMC12208316 | biostudies-literature
UnknownMicroscaled proteogenomic methods for precision oncology.
Not available
S-EPMC6985126 | biostudies-literature
UnknownProteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
Not available
S-EPMC9627136 | biostudies-literature
UnknownIntegrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer.
Not available
S-EPMC12641601 | biostudies-literature
UnknownProteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities.
Not available
S-EPMC6768830 | biostudies-literature
UnknownProteogenomic integration reveals therapeutic targets in breast cancer xenografts.
Not available
S-EPMC5379071 | biostudies-literature
UnknownMass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers.
Not available
S-EPMC5955814 | biostudies-literature
ProteomicsMicroscaled Proteogenomic Methods for Precision Oncology

Shankha Satpathy, Eric J. Jaehnig, et al., Nature Communications volume 11, Article number: 532 (2020)

Cancer proteogenomics promises new insights into cancer biology and treatment efficacy by integrating genom...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606) Mus Musculus (ncbitaxon:10090) 
2021-06-02 | MSV000087566 | MassIVE
UnknownProteogenomics connects somatic mutations to signalling in breast cancer.
Not available
S-EPMC5102256 | biostudies-literature
Sort   by:  
 Page size